Aurobindo Pharma shareholders and shareholding pattern
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Last close ₹1,571.70down ₹39.20 (2.43%)BSE ₹1,569.30
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,610.90.
52-week range of traded prices to 23 Oct 2026
₹1,080.10Low, 24 Oct 2025₹1,740.00High, 24 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹90,432 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 24.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 21 May 2026
- 2.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 5 Aug 2026
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 21 May 2026
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,50,60251.3% delivered
Who owns Aurobindo Pharma, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters51.88%
- Foreign institutions17.41%
- Indian institutions24.42%
- GovernmentsNone
- Individuals and others6.29%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Governments
- Individuals and others
| Per cent | Dec 2016Filed 9 Jan | Mar 2017Filed 13 Apr | Jun 2017Filed 13 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 10 Jan | Mar 2018Filed 11 Apr | Jun 2018Filed 11 Jul | Sep 2018Filed 15 Oct | Dec 2018Filed 24 Jan | Mar 2019Filed 12 Apr | Jun 2019Filed 19 Jul | Sep 2019Filed 17 Oct | Dec 2019Filed 10 Jan | Mar 2020Filed 29 Apr | Jun 2020Filed 17 Jul | Sep 2020Filed 19 Oct | Dec 2020Filed 19 Jan | Mar 2021Filed 17 Apr | Jun 2021Filed 16 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 17 Jan | Mar 2022Filed 16 Apr | Jun 2022Filed 18 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 17 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 16 Oct | Dec 2023Filed 8 Jan | Mar 2024Filed 5 Apr | Jun 2024Filed 9 Jul | Sep 2024Filed 14 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 15 Apr | Jun 2025Filed 15 Jul | Sep 2025Filed 13 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 15 Jul | Sep 2026Filed 14 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.94% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 51.87% | 52.01% | 52.01% | 52.01% | 51.94% | 51.94% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.83% | 51.80% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.88% | 51.88% | |
| Indian promoters | 48.86% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.80% | 48.94% | 48.94% | 48.94% | 48.86% | 48.86% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.76% | 48.73% | 48.75% | 48.75% | 48.75% | 48.75% | 48.75% | 48.75% | 48.75% | 48.81% | 48.80% |
| Foreign promoters | 3.08% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% | 3.07% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 48.06% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 48.13% | 47.99% | 47.99% | 47.99% | 48.06% | 48.06% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.17% | 48.20% | 48.18% | 48.18% | 48.18% | 48.18% | 48.18% | 48.18% | 48.18% | 48.12% | 48.12% |
| Promoter shares pledgedShare of the promoters' own shares | 1.40% | 1.27% | 1.22% | 1.53% | 1.79% | 2.01% | 2.09% | 2.21% | 2.30% | 3.49% | 3.82% | 4.20% | 4.99% | 6.17% | 6.17% | 9.34% | 9.27% | 22.81% | 20.66% | 22.98% | 22.97% | 14.05% | 14.97% | 14.92% | 16.15% | 17.90% | 19.16% | 19.56% | 18.90% | 20.86% | 20.88% | 20.39% | 17.83% | 16.92% | 17.08% | 17.50% | 17.50% | 23.65% | 13.75% | 11.99% |
| Shares in issue | 58,51,69,586 | 58,58,82,409 | 58,58,82,409 | 58,58,82,409 | 58,58,82,409 | 58,59,07,609 | 58,59,07,609 | 58,59,07,609 | 58,59,07,609 | 58,59,15,609 | 58,59,15,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,59,38,609 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 58,08,01,623 | 57,53,77,895 | 57,53,77,895 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Aurobindo Pharma promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING), 33.54%. The filing names 1 more member with no shares.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| RPR SONS ADVISORS PRIVATE LIMITED, MRS.P.SUNEELA RANI (JOINTLY HOLDING)Indian companies, trusts and others | 33.54% | 19,29,97,923 | 10.95% |
| KAMBAM NITHYANANDA REDDYIndividuals and Hindu undivided families | 4.37% | 2,51,48,052 | 41.55% |
| KIRTHI REDDY KAMBAMIndividuals and Hindu undivided families | 3.46% | 1,99,01,635 | 13.57% |
| VENKATA RAMPRASAD REDDY PENAKANon-resident and foreign individuals | 3.07% | 1,76,90,341 | 0.00% |
| AXIS CLINICALS LIMITED, TRIDENT CHEMPHAR LIMITED, RPR SONS ADVISORS PVT.LTD. (JOINTLY HOLDING)Indian companies, trusts and others | 2.86% | 1,64,38,963 | 0.00% |
| MEENAKSHISUNDERAM SIVAKUMARANIndividuals and Hindu undivided families | 2.48% | 1,42,42,061 | 0.00% |
| KAMBAM SPOORTHIIndividuals and Hindu undivided families | 1.20% | 68,83,414 | 5.81% |
| KOTTAMANCHI RAJESWARIIndividuals and Hindu undivided families | 0.31% | 17,94,100 | 11.15% |
| M SUMANTH KUMAR REDDYIndividuals and Hindu undivided families | 0.27% | 15,72,477 | 50.88% |
| TRIDENT CHEMPHAR LIMITEDIndian companies, trusts and others | 0.13% | 7,75,957 | 0.00% |
| AXIS CLINICALS LIMITEDIndian companies, trusts and others | 0.11% | 6,46,682 | 0.00% |
| PRASADA REDDY KAMBHAMIndividuals and Hindu undivided families | 0.05% | 2,70,976 | 36.90% |
Pledged is the share of the holder's own shares pledged to a lender.
Largest public holders of Aurobindo Pharma, filing by filing
Per cent, on the same shares as the split above.Mutual funds holding Aurobindo Pharma
| Holder | Dec 2016Filed 9 Jan | Mar 2017Filed 13 Apr | Jun 2017Filed 13 Jul | Sep 2017Filed 12 Oct | Dec 2017Filed 10 Jan | Mar 2018Filed 11 Apr | Jun 2018Filed 11 Jul | Sep 2018Filed 15 Oct | Dec 2018Filed 24 Jan | Mar 2019Filed 12 Apr | Jun 2019Filed 19 Jul | Sep 2019Filed 17 Oct | Dec 2019Filed 10 Jan | Mar 2020Filed 29 Apr | Jun 2020Filed 17 Jul | Sep 2020Filed 19 Oct | Dec 2020Filed 19 Jan | Mar 2021Filed 17 Apr | Jun 2021Filed 16 Jul | Sep 2021Filed 12 Oct | Dec 2021Filed 17 Jan | Mar 2022Filed 16 Apr | Jun 2022Filed 18 Jul | Sep 2022Filed 20 Oct | Dec 2022Filed 17 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 16 Oct | Dec 2023Filed 8 Jan | Mar 2024Filed 5 Apr | Jun 2024Filed 9 Jul | Sep 2024Filed 14 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 15 Apr | Jun 2025Filed 15 Jul | Sep 2025Filed 13 Oct | Dec 2025Filed 13 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 15 Jul | Sep 2026Filed 14 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIFE INSURANCE CORPORATION OF INDIAInsurance companies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.91% | 3.46% | 4.34% | 5.33% | 5.48% | 5.48% | 5.48% | 5.57% | 5.57% | 5.55% | 5.43% | 3.81% | 3.38% | 2.78% | 2.08% | 2.08% | 2.45% | 2.49% | 2.91% | 2.91% | 2.93% | 2.94% | 2.85% |
| NPS TRUST A/C - SBI PENSION FUND - UPS - CG SCHEMProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.23% | – | – | 2.80% |
| NPS TRUST - A/C SBI PENSION FUND SCHEME - NPS TIERProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.74% | – |
| NPS TRUST- A/C ICICI PRUDENTIAL PENSION FUND SCHEMProvident and pension funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.57% | 1.92% | 2.20% | 2.10% | 2.11% | – | 2.34% | In concert | – |
| BNP PARIBAS FINANCIAL MARKETSForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.62% | – | – | – | – | – | – | – | – | – | – | – |
| BNP PARIBAS ARBITRAGEForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | 1.04% | 1.08% | 1.21% | In concert | 1.22% | 1.22% | 1.15% | 1.19% | 1.12% | 1.19% | 1.22% | In concert | 1.24% | 1.41% | – | – | – | – | – | – | – | – | – | – | – | – |
| INVESCO ASIAN EQUITY INCOME FUND (UK)Foreign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | In concert | In concert | 1.12% | – | – | – | – | – | – | – | – | – | – | – | – | – |
| BNP PARIBAS ARBITRAGE - ODIForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | In concert | In concert | In concert | In concert | 1.26% | In concert | In concert | In concert | In concert | In concert | In concert | In concert | 1.37% | In concert | In concert | – | – | – | – | – | – | – | – | – | – | – | – |
| INVESCO PACIFIC FUND (UK)Foreign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | 1.17% | In concert | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SAUDI ARABIAN MONETARY AUTHORITY - EMERGING MARKETInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITEDOther Institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ABU DHABI INVESTMENT AUTHORITY - BEACONInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | 1.11% | 1.05% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AMANSA HOLDINGS PRIVATE LIMITEDInstitutions Foreign Portfolio Investor | – | – | – | – | – | 1.18% | 1.20% | 1.20% | 1.08% | 1.08% | 1.14% | 1.26% | 1.17% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| STICHTING DEPOSITARY APG EMERGING MARKETS EQUITY POOLInstitutions Foreign Portfolio Investor | 1.09% | 1.10% | – | 1.07% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| JHUNJHUNWALA RAKESH RADHESHYAMResident individuals, over ₹2 lakh at face value | – | 1.08% | 1.12% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ABU DHABI INVESTMENT AUTHORITY - BEHAVEInstitutions Foreign Portfolio Investor | 1.31% | 1.02% | – | – | – | – | – | – | – | – | – | In concert | – | In concert | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RAKESH JHUNJHUNWALAResident individuals, over ₹2 lakh at face value | 1.09% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent. “In concert” is a filing that named the holder only among the persons acting in concert; the latest filing's list is below.
Persons acting in concert
From the filing for Sep 2026.
| NamePersons acting in concert. Shareholders who have agreed to act together in the company, such as members of a family or a fund house and its schemes, listed together in the filing with what each holds. | Holding | Shares |
|---|---|---|
| QUANT MUTUAL FUND - QUANT ARBITRAGE FUND | 0.01% | 49,500 |
| QUANT MUTUAL FUND - QSIF SECTOR ROTATION LONG - SHORT FUND | 0.00% | 10,948 |
| QUANT MUTUAL FUND - QUANT DYNAMIC ASSET ALLOCATION FUND | 0.09% | 4,96,695 |
| QUANT MUTUAL FUND - QUANT BUSINESS CYCLE FUND | 0.10% | 5,77,381 |
| QUANT MUTUAL FUND - QUANT MANUFACTURING FUND | 0.07% | 4,23,544 |
| QUANT MUTUAL FUND - QUANT HEALTHCARE FUND | 0.02% | 1,29,172 |
| QUANT MUTUAL FUND - QUANT MOMENTUM FUND | 0.12% | 7,08,612 |
| QUANT MUTUAL FUND - QUANT CONSUMPTION FUND | 0.02% | 96,058 |
| QUANT MUTUAL FUND-QUANT ELSS TAX SAVER FUND | 1.16% | 66,52,259 |
| QUANT MUTUAL FUND - QUANT MID CAP FUND | 0.85% | 49,02,846 |
| QUANT MUTUAL FUND - QUANT AGGRESSIVE HYBRID FUND | 0.18% | 10,12,165 |
| QUANT MUTUAL FUND - QUANT MULTI CAP FUND | 0.74% | 42,57,303 |
Shareholders who act together in the company, with what each holds. The list can repeat holders shown above, under another name or as one of a fund house's schemes.